Literature DB >> 8234289

An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation.

K Shimizu1, H Ichikawa, A Tojo, Y Kaneko, N Maseki, Y Hayashi, M Ohira, S Asano, M Ohki.   

Abstract

The t(16;21)(p11;q22) translocation is a nonrandom chromosomal abnormality found in several types of myeloid leukemia, which show variable cytomorphological features. We constructed rodent-human somatic cell hybrids containing the der(16) chromosome from leukemic cells of a patient with t(16;21). Using these hybrids, we mapped the translocation breakpoint on the Not I restriction map of chromosome 21 which we had previously constructed. The result showed the proximity of the breakpoint to the ERG gene, a member of the ets oncogene superfamily. Polymerase chain reaction and Southern blot analyses of genomic DNA from the hybrids and from peripheral blood cells and bone marrow cells of patients with t(16;21) showed that the breakpoints were clustered within a single intron in the coding region of the ERG gene. This finding and the results obtained by Northern blot analysis suggested the formation of a chimeric product(s) by fusion of the ERG gene and an unknown counterpart gene on chromosome 16.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234289      PMCID: PMC47758          DOI: 10.1073/pnas.90.21.10280

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids.

Authors:  M L Van Keuren; P C Watkins; H A Drabkin; E W Jabs; J F Gusella; D Patterson
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Translocation (8;21) and its variants in acute nonlymphocytic leukemia. The relative importance of chromosomes 8 and 21 to the genesis of the disease.

Authors:  M Minamihisamatsu; T Ishihara
Journal:  Cancer Genet Cytogenet       Date:  1988-07-15

4.  The erg gene: a human gene related to the ets oncogene.

Authors:  E S Reddy; V N Rao; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  Translocation t(16;21) in acute nonlymphocytic leukemia with abnormal eosinophils.

Authors:  E Yao; N Sadamori; H Nakamura; I Sasagawa; T Itoyama; M Ichimaru; M Tagawa; I Nakamura; T Kamei
Journal:  Cancer Genet Cytogenet       Date:  1988-12

6.  Isolation and regional mapping of DNA sequences unique to human chromosome 21.

Authors:  J R Korenberg; M L Croyle; D R Cox
Journal:  Am J Hum Genet       Date:  1987-12       Impact factor: 11.025

7.  A NotI restriction map of the entire long arm of human chromosome 21.

Authors:  H Ichikawa; F Hosoda; Y Arai; K Shimizu; M Ohira; M Ohki
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

8.  Adenine phosphoribosyltransferase deficiency in cultured mouse mammary tumor FM3A cells resistant to 4-carbamoylimidazolium 5-olate.

Authors:  H Koyama; H Kodama
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

9.  erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation.

Authors:  V N Rao; T S Papas; E S Reddy
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

10.  The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active.

Authors:  D K Watson; M J McWilliams-Smith; M F Nunn; P H Duesberg; S J O'Brien; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

View more
  42 in total

1.  Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).

Authors:  H Ichikawa; K Shimizu; R Katsu; M Ohki
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.

Authors:  Natasza A Kurpios; Nancy A Sabolic; Trevor G Shepherd; Gina M Fidalgo; John A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

3.  Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage.

Authors:  Elizabeth A Kruse; Stephen J Loughran; Tracey M Baldwin; Emma C Josefsson; Sarah Ellis; Dennis K Watson; Paquita Nurden; Donald Metcalf; Douglas J Hilton; Warren S Alexander; Benjamin T Kile
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-31       Impact factor: 11.205

4.  Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells.

Authors:  D S Pereira; C Dorrell; C Y Ito; O I Gan; B Murdoch; V N Rao; J P Zou; E S Reddy; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

5.  A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites.

Authors:  P J Valk; M Joosten; Y Vankan; B Löwenberg; R Delwel
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

Review 6.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

Review 7.  The ETS family of oncogenic transcription factors in solid tumours.

Authors:  Gina M Sizemore; Jason R Pitarresi; Subhasree Balakrishnan; Michael C Ostrowski
Journal:  Nat Rev Cancer       Date:  2017-04-28       Impact factor: 60.716

8.  Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.

Authors:  Ying Xie; Mia Lee Koch; Xin Zhang; Melanie J Hamblen; Frank J Godinho; Yuko Fujiwara; Huafeng Xie; Jan-Henning Klusmann; Stuart H Orkin; Zhe Li
Journal:  Stem Cells       Date:  2017-04-24       Impact factor: 6.277

Review 9.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.

Authors:  S-M Oh; Z Liu; M Okada; S-W Jang; X Liu; C-B Chan; H Luo; K Ye
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.